Dr. Gloria Bedini is a young biologist researcher. She graduated in Biological Science at the “Università degli Studi di Pavia” (Italy) in 2009 contributing to a study on the role of the focal adhesion kinase Pyk2 in human and murine platelets. In 2015, she obtained also her Specialization in Clinical Biochemistry (Università degli Studi di Milano; Italy). During this period, she increased her scientific interest in the development of new cellular human in vitro model for rare neurological disease [Dossena and Bedini, et al. PLoS One. 2014 Nov 13;9(11): e112746], and understanding of key developmental pathways and how alterations in gene expression contribute to human disease. In the last context, Dr. Bedini had the possibility to accomplish a study on the evaluation of genetics parameters of disorder of consciousness patients becoming the first author of the innovative paper “Is Period3 Genotype Associated with Sleep and Recovery in Patients with Disorders of Consciousness?” [Bedini et al. Neurorehabil Neural Repair. 2016 Jun;30(5):461-69], for which she will receive the “2016 CERGAS-BOCCONI VIVISALUTE” award. In this last two years, her interest was directed to the knowledge of rare cerebrovascular diseases. Particularly, in 2014 she contributed to implement the first Moyamoya Italian network (GENetics of Moya-moyA-GEN-O-MA project) including 20 stroke Italian centers interested in MA study. This network, which is joined to the European Moyamoya initiative, allowed to implement a detailed dataset of Caucasian MA patients and finalized to understand the unknown pathophysiology of the disease.

Dr. Gloria Bedini's research is focused on Stroke, Moyamoya Disease, Rare Cerebrovascular Diseases, Mesenchymal Stem Cells, and Disorder of Consciousness.